A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Clinical trial NCT05357989 · COMPLETED

Trial details

NCT number: NCT05357989
Sponsor: Annovis Bio Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease, Idiopathic

Start date: 2022-08-03
Primary completion: 2023-12-04
Enrollment: 523

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.